Published in PLoS One on December 24, 2009
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease. Nat Rev Neurosci (2010) 3.14
LRRK2 is involved in the IFN-gamma response and host response to pathogens. J Immunol (2010) 1.85
Membrane localization of LRRK2 is associated with increased formation of the highly active LRRK2 dimer and changes in its phosphorylation. Biochemistry (2010) 1.47
LRRK2 kinase activity is dependent on LRRK2 GTP binding capacity but independent of LRRK2 GTP binding. PLoS One (2011) 1.19
Regulation of LRRK2 expression points to a functional role in human monocyte maturation. PLoS One (2011) 1.15
The G2385R variant of leucine-rich repeat kinase 2 associated with Parkinson's disease is a partial loss-of-function mutation. Biochem J (2012) 1.11
Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease? BMC Med (2012) 1.10
Biochemical characterization of highly purified leucine-rich repeat kinases 1 and 2 demonstrates formation of homodimers. PLoS One (2012) 1.09
LRRK2 Parkinson disease mutations enhance its microtubule association. Hum Mol Genet (2011) 1.08
Receptor-interacting protein (RIP) kinase family. Cell Mol Immunol (2010) 1.07
Leucine-rich repeat kinase 2 (LRRK2) as a potential therapeutic target in Parkinson's disease. Trends Pharmacol Sci (2012) 1.04
LRRK2 kinase activity and biology are not uniformly predicted by its autophosphorylation and cellular phosphorylation site status. Front Mol Neurosci (2014) 1.03
LRRK2 pathobiology in Parkinson's disease. J Neurochem (2014) 0.97
Leucine-rich repeat kinase 2 binds to neuronal vesicles through protein interactions mediated by its C-terminal WD40 domain. Mol Cell Biol (2014) 0.96
Heterogeneity of leucine-rich repeat kinase 2 mutations: genetics, mechanisms and therapeutic implications. Neurotherapeutics (2014) 0.94
Ten years and counting: moving leucine-rich repeat kinase 2 inhibitors to the clinic. Mov Disord (2014) 0.94
Expression analysis of Lrrk1, Lrrk2 and Lrrk2 splice variants in mice. PLoS One (2013) 0.93
Cellular effects of LRRK2 mutations. Biochem Soc Trans (2012) 0.90
Structural biology of the LRRK2 GTPase and kinase domains: implications for regulation. Front Mol Neurosci (2014) 0.89
LRRK2, a puzzling protein: insights into Parkinson's disease pathogenesis. Exp Neurol (2014) 0.88
Number and brightness analysis of LRRK2 oligomerization in live cells. Biophys J (2012) 0.87
Contribution of GTPase activity to LRRK2-associated Parkinson disease. Small GTPases (2013) 0.87
Leucine-rich repeat kinase 2 for beginners: six key questions. Cold Spring Harb Perspect Med (2012) 0.86
Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson's disease? Mol Neurodegener (2011) 0.85
The role of the LRRK2 gene in Parkinsonism. Mol Neurodegener (2014) 0.85
The Multifunctions of WD40 Proteins in Genome Integrity and Cell Cycle Progression. J Genomics (2015) 0.84
LRRK2: an éminence grise of Wnt-mediated neurogenesis? Front Cell Neurosci (2013) 0.83
Association of the LRRK2 genetic polymorphisms with leprosy in Han Chinese from Southwest China. Genes Immun (2014) 0.82
Arsenite stress down-regulates phosphorylation and 14-3-3 binding of leucine-rich repeat kinase 2 (LRRK2), promoting self-association and cellular redistribution. J Biol Chem (2014) 0.82
Evolution of neurodegeneration. Curr Biol (2012) 0.79
The function of orthologues of the human Parkinson's disease gene LRRK2 across species: implications for disease modelling in preclinical research. Biochem J (2016) 0.79
Activation Mechanism of LRRK2 and Its Cellular Functions in Parkinson's Disease. Parkinsons Dis (2016) 0.78
Nemitin, a novel Map8/Map1s interacting protein with Wd40 repeats. PLoS One (2012) 0.77
Vacuolar protein sorting receptor in Giardia lamblia. PLoS One (2012) 0.76
Unravelling the role of defective genes. Prog Brain Res (2010) 0.76
Evaluating LRRK2 genetic variants with unclear pathogenicity. Biomed Res Int (2015) 0.75
Activation of FADD-Dependent Neuronal Death Pathways as a Predictor of Pathogenicity for LRRK2 Mutations. PLoS One (2016) 0.75
Leucine-rich repeat kinase-1 regulates osteoclast function by modulating RAC1/Cdc42 Small GTPase phosphorylation and activation. Am J Physiol Endocrinol Metab (2016) 0.75
Role and mechanism of action of leucine-rich repeat kinase 1 in bone. Bone Res (2017) 0.75
G2385R and I2020T Mutations Increase LRRK2 GTPase Activity. Biomed Res Int (2016) 0.75
The LRRK2 G2385R variant is a partial loss-of-function mutation that affects synaptic vesicle trafficking through altered protein interactions. Sci Rep (2017) 0.75
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 665.31
The Protein Data Bank. Nucleic Acids Res (2000) 187.10
The WD repeat: a common architecture for diverse functions. Trends Biochem Sci (1999) 8.39
Distance-scaled, finite ideal-gas reference state improves structure-derived potentials of mean force for structure selection and stability prediction. Protein Sci (2002) 7.40
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci U S A (2005) 6.98
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol Dis (2006) 5.96
Molecular pathophysiology of Parkinson's disease. Annu Rev Neurosci (2005) 5.93
Kinase activity of mutant LRRK2 mediates neuronal toxicity. Nat Neurosci (2006) 5.32
LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity. Biochem J (2007) 3.89
Genetics of Parkinson's disease and parkinsonism. Ann Neurol (2006) 3.60
LRRK2 in Parkinson's disease: protein domains and functional insights. Trends Neurosci (2006) 3.58
Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila. EMBO J (2008) 3.51
The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity. Hum Mol Genet (2005) 3.49
Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatry (1997) 3.14
Using multiple structure alignments, fast model building, and energetic analysis in fold recognition and homology modeling. Proteins (2003) 3.04
The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation. J Biol Chem (2008) 2.77
The R1441C mutation of LRRK2 disrupts GTP hydrolysis. Biochem Biophys Res Commun (2007) 2.42
Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson's disease R1441C/G mutants. J Neurochem (2007) 2.40
Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase. Proc Natl Acad Sci U S A (2008) 2.36
The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity. Exp Cell Res (2007) 2.27
A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan. Neurogenetics (2006) 2.10
The chaperone activity of heat shock protein 90 is critical for maintaining the stability of leucine-rich repeat kinase 2. J Neurosci (2008) 1.86
LRRK1 protein kinase activity is stimulated upon binding of GTP to its Roc domain. Cell Signal (2005) 1.74
Apoptotic mechanisms in mutant LRRK2-mediated cell death. Hum Mol Genet (2007) 1.72
Mutations in LRRK2/dardarin associated with Parkinson disease are more toxic than equivalent mutations in the homologous kinase LRRK1. J Neurochem (2007) 1.70
Structure of the Roc-COR domain tandem of C. tepidum, a prokaryotic homologue of the human LRRK2 Parkinson kinase. EMBO J (2008) 1.62
Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia. Parkinsonism Relat Disord (2007) 1.56
The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubules. J Neurosci Res (2008) 1.54
Rare genetic mutations shed light on the pathogenesis of Parkinson disease. J Clin Invest (2003) 1.52
Identification of potential protein interactors of Lrrk2. Parkinsonism Relat Disord (2007) 1.44
The Parkinson disease protein leucine-rich repeat kinase 2 transduces death signals via Fas-associated protein with death domain and caspase-8 in a cellular model of neurodegeneration. J Neurosci (2009) 1.42
On the role of structural information in remote homology detection and sequence alignment: new methods using hybrid sequence profiles. J Mol Biol (2003) 1.34
The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence. Hum Genet (2006) 1.27
Leucine-rich repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian population. Neuroreport (2007) 1.23
Impact of recent genetic findings in Parkinson's disease. Curr Opin Neurol (2007) 1.22
Genetics of Parkinson's disease. Hum Mol Genet (1997) 1.13
Thirty-plus functional families from a single motif. Protein Sci (2000) 1.12
Intramolecular activation mechanism of the Dictyostelium LRRK2 homolog Roco protein GbpC. J Biol Chem (2008) 1.11
Ancient origin of the Parkinson disease gene LRRK2. J Mol Evol (2008) 1.11
Proteasomal inhibition-induced inclusion formation and death in cortical neurons require transcription and ubiquitination. Mol Cell Neurosci (2002) 1.05
Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's disease. Neurogenetics (2007) 0.96
Societal costs of exposure to toxic substances: economic and health costs of four case studies that are candidates for environmental causation. Environ Health Perspect (2001) 0.88
Hsp70/Hsc70 regulates the effect phosphorylation has on stabilizing ataxin-1. J Neurochem (2007) 0.84
Lrrk2 in the limelight! Neurology (2007) 0.82
Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science (2011) 13.16
The role of DNA shape in protein-DNA recognition. Nature (2009) 5.52
Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem (2005) 5.33
The developmental dynamics of the maize leaf transcriptome. Nat Genet (2010) 4.02
Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron (2005) 3.75
Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation (2010) 3.42
Cofactor binding evokes latent differences in DNA binding specificity between Hox proteins. Cell (2011) 3.40
Structure-based prediction of protein-protein interactions on a genome-wide scale. Nature (2012) 3.37
Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming. Cell (2013) 3.13
Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol Cell Biol (2002) 2.58
Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science (2006) 2.49
A comparison of statistical methods for detecting differentially expressed genes from RNA-seq data. Am J Bot (2012) 2.44
A critical evaluation of the Braak staging scheme for Parkinson's disease. Ann Neurol (2008) 2.44
Protein structure comparison: implications for the nature of 'fold space', and structure and function prediction. Curr Opin Struct Biol (2006) 2.37
Designing a wearable navigation system for image-guided cancer resection surgery. Ann Biomed Eng (2014) 2.33
Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutation. Proc Natl Acad Sci U S A (2004) 2.19
A brassinosteroid transcriptional network revealed by genome-wide identification of BESI target genes in Arabidopsis thaliana. Plant J (2011) 2.19
Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation. Nat Genet (2005) 2.10
The AAA+ protein torsinA interacts with a conserved domain present in LAP1 and a novel ER protein. J Cell Biol (2005) 1.89
Protein interface conservation across structure space. Proc Natl Acad Sci U S A (2010) 1.82
Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry (2005) 1.76
Scaling up prevention programmes to reduce the sexual transmission of HIV in China. Int J Epidemiol (2010) 1.71
Pathological roles of α-synuclein in neurological disorders. Lancet Neurol (2011) 1.71
GAP production of TCM herbs in China. Planta Med (2010) 1.70
miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. Brain Res Bull (2009) 1.66
A low-cost library construction protocol and data analysis pipeline for Illumina-based strand-specific multiplex RNA-seq. PLoS One (2011) 1.60
PrePPI: a structure-informed database of protein-protein interactions. Nucleic Acids Res (2012) 1.59
Microstructure abnormalities in adolescents with internet addiction disorder. PLoS One (2011) 1.56
Inhibiting expression of specific genes in mammalian cells with 5' end-mutated U1 small nuclear RNAs targeted to terminal exons of pre-mRNA. Proc Natl Acad Sci U S A (2003) 1.55
Obligate heterodimerization of Arabidopsis phytochromes C and E and interaction with the PIF3 basic helix-loop-helix transcription factor. Plant Cell (2009) 1.52
A molecular mechanism underlying the neural-specific defect in torsinA mutant mice. Proc Natl Acad Sci U S A (2010) 1.51
Primary dystonia: molecules and mechanisms. Nat Rev Neurol (2009) 1.51
A mixed-solvent strategy for efficient exfoliation of inorganic graphene analogues. Angew Chem Int Ed Engl (2011) 1.47
Resistance to obesity by repression of VEGF gene expression through induction of brown-like adipocyte differentiation. Endocrinology (2012) 1.47
miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes. Carcinogenesis (2012) 1.45
Primary non-Hodgkin lymphomas in the small and large intestine: clinicopathological characteristics and management of 40 patients. Int J Hematol (2008) 1.45
Polymorphisms and haplotypes in multidrug resistance 1 gene are not associated with chronic lymphocytic leukemia susceptibility and prognostic parameters of chronic lymphocytic leukemia in Chinese population. Leuk Lymphoma (2011) 1.44
The Parkinson disease protein leucine-rich repeat kinase 2 transduces death signals via Fas-associated protein with death domain and caspase-8 in a cellular model of neurodegeneration. J Neurosci (2009) 1.42
Characterization of 582 natural and synthetic terminators and quantification of their design constraints. Nat Methods (2013) 1.42
Long-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5. Proc Natl Acad Sci U S A (2014) 1.39
Necroptosis: an emerging form of programmed cell death. Crit Rev Oncol Hematol (2011) 1.38
Transferrin receptor-targeted lipid nanoparticles for delivery of an antisense oligodeoxyribonucleotide against Bcl-2. Mol Pharm (2009) 1.37
Plasma soluble corin in patients with heart failure. Circ Heart Fail (2010) 1.36
Computational explorations of mechanisms and ligand-directed selectivities of copper-catalyzed Ullmann-type reactions. J Am Chem Soc (2010) 1.36
A map of minor groove shape and electrostatic potential from hydroxyl radical cleavage patterns of DNA. ACS Chem Biol (2011) 1.35
Cerebellothalamocortical pathway abnormalities in torsinA DYT1 knock-in mice. Proc Natl Acad Sci U S A (2011) 1.33
Receptor-like kinase OsSIK1 improves drought and salt stress tolerance in rice (Oryza sativa) plants. Plant J (2010) 1.32
Clinical features of solitary necrotic nodule of the liver. Hepatobiliary Pancreat Dis Int (2008) 1.32
Nuance in the double-helix and its role in protein-DNA recognition. Curr Opin Struct Biol (2009) 1.32
Stress-induced alternative splicing provides a mechanism for the regulation of microRNA processing in Arabidopsis thaliana. Mol Cell (2012) 1.31
Polycomb protein Cbx4 promotes SUMO modification of de novo DNA methyltransferase Dnmt3a. Biochem J (2007) 1.29
A multi-treatment experimental system to examine photosynthetic differentiation in the maize leaf. BMC Genomics (2007) 1.29
TorsinA hypofunction causes abnormal twisting movements and sensorimotor circuit neurodegeneration. J Clin Invest (2014) 1.28
Suzuki-Miyaura cross-coupling of aryl carbamates and sulfamates: experimental and computational studies. J Am Chem Soc (2011) 1.26
Thymidine kinase 2 (H126N) knockin mice show the essential role of balanced deoxynucleotide pools for mitochondrial DNA maintenance. Hum Mol Genet (2008) 1.26
PredUs: a web server for predicting protein interfaces using structural neighbors. Nucleic Acids Res (2011) 1.25
Time-varied characteristics of acupuncture effects in fMRI studies. Hum Brain Mapp (2009) 1.23
The opposite-direction modulation of CD4+CD25+ Tregs and T helper 1 cells in acute coronary syndromes. Clin Immunol (2007) 1.22
A first generation microsatellite- and SNP-based linkage map of Jatropha. PLoS One (2011) 1.19
Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma. Ann Hematol (2011) 1.19
Catalytic ketyl-olefin cyclizations enabled by proton-coupled electron transfer. J Am Chem Soc (2013) 1.19
Crystal structure of human vacuolar protein sorting protein 29 reveals a phosphodiesterase/nuclease-like fold and two protein-protein interaction sites. J Biol Chem (2005) 1.17
Mechanisms of immune system activation in glaucoma: oxidative stress-stimulated antigen presentation by the retina and optic nerve head glia. Invest Ophthalmol Vis Sci (2007) 1.16
MicroRNAs activate natural killer cells through Toll-like receptor signaling. Blood (2013) 1.15
Biotransformation and metabolic profile of American ginseng saponins with human intestinal microflora by liquid chromatography quadrupole time-of-flight mass spectrometry. J Chromatogr A (2013) 1.15
IR-780 dye loaded tumor targeting theranostic nanoparticles for NIR imaging and photothermal therapy. Biomaterials (2013) 1.14
Regulation of alpha-synuclein by bFGF in cultured ventral midbrain dopaminergic neurons. J Neurochem (2003) 1.14
Transcriptome-wide changes in Chlamydomonas reinhardtii gene expression regulated by carbon dioxide and the CO2-concentrating mechanism regulator CIA5/CCM1. Plant Cell (2012) 1.14
Effects of controlled-release fertiliser on nitrogen use efficiency in summer maize. PLoS One (2013) 1.13
alpha-synuclein is required for the fibrillar nature of ubiquitinated inclusions induced by proteasomal inhibition in primary neurons. J Biol Chem (2004) 1.13
N'-(3,5-Dichloro-2-hydroxy-benzyl-idene)-3-methoxy-benzohydrazide methanol solvate. Acta Crystallogr Sect E Struct Rep Online (2008) 1.12
Origins of differences in reactivities of alkenes, alkynes, and allenes in [Rh(CO)2Cl]2-catalyzed (5 + 2) cycloaddition reactions with vinylcyclopropanes. J Am Chem Soc (2008) 1.12
Neurobiology of alpha-synuclein. Mol Neurobiol (2004) 1.10
Proteasome inhibition and Parkinson's disease modeling. Ann Neurol (2006) 1.10
Downregulation of HtrA1 promotes resistance to anoikis and peritoneal dissemination of ovarian cancer cells. Cancer Res (2010) 1.10
Improving gas sensing properties of graphene by introducing dopants and defects: a first-principles study. Nanotechnology (2009) 1.10
Mechanism and transition-state structures for nickel-catalyzed reductive alkyne-aldehyde coupling reactions. J Am Chem Soc (2009) 1.09
HSulf-1 modulates FGF2- and hypoxia-mediated migration and invasion of breast cancer cells. Cancer Res (2011) 1.09
Decomposition pathways of Z-selective ruthenium metathesis catalysts. J Am Chem Soc (2012) 1.09
Endonuclease-mediated mRNA decay requires tyrosine phosphorylation of polysomal ribonuclease 1 (PMR1) for the targeting and degradation of polyribosome-bound substrate mRNA. J Biol Chem (2004) 1.09
Donor-acceptor conjugated polymer based on naphtho[1,2-c:5,6-c]bis[1,2,5]thiadiazole for high-performance polymer solar cells. J Am Chem Soc (2011) 1.08
Phytoremediation of urban wastewater by model wetlands with ornamental hydrophytes. J Environ Sci (China) (2007) 1.08
Biocompatible graphene oxide nanoparticle-based drug delivery platform for tumor microenvironment-responsive triggered release of doxorubicin. Langmuir (2014) 1.08
LRRK2 Parkinson disease mutations enhance its microtubule association. Hum Mol Genet (2011) 1.08
Ramosetron versus ondansetron in the prevention of chemotherapy-induced gastrointestinal side effects: A prospective randomized controlled study. Chemotherapy (2007) 1.07
Model-based clustering for RNA-seq data. Bioinformatics (2013) 1.07
Mechanisms of caspase-independent neuronal death: energy depletion and free radical generation. J Neurosci (2003) 1.07
Clinical features of hepatic angiomyolipoma. Hepatobiliary Pancreat Dis Int (2008) 1.07
Cardiac troponin: a villain or a decent actor in the process of ongoing myocardial injury? J Am Coll Cardiol (2013) 1.07
Genetic polymorphisms and treatment response in advanced non-small cell lung cancer. Lung Cancer (2007) 1.07
Mapping QTLs for oil traits and eQTLs for oleosin genes in jatropha. BMC Plant Biol (2011) 1.07
Leaf rolling controlled by the homeodomain leucine zipper class IV gene Roc5 in rice. Plant Physiol (2011) 1.07
Origin of enantioselectivity in CF3-PIP-catalyzed kinetic resolution of secondary benzylic alcohols. J Am Chem Soc (2008) 1.07
Lamina-associated polypeptide-1 interacts with the muscular dystrophy protein emerin and is essential for skeletal muscle maintenance. Dev Cell (2013) 1.07
Higher ratio of triglyceride to high-density lipoprotein cholesterol may predispose to diabetes mellitus: 15-year prospective study in a general population. Metabolism (2011) 1.06
Identification and characterization of selenoprotein K: an antioxidant in cardiomyocytes. FEBS Lett (2006) 1.06
A membrane microdomain-associated protein, Arabidopsis Flot1, is involved in a clathrin-independent endocytic pathway and is required for seedling development. Plant Cell (2012) 1.06
Impaired fitness and transmission of macrolide-resistant Campylobacter jejuni in its natural host. Antimicrob Agents Chemother (2011) 1.05